💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Alnylam Pharmaceuticals, Inc. (ALNY)
« Back to company indexALNY Chatter Timeline
Stock Ticker for ALNY
Most Active Tweeters for ALNY
| User | Tweets |
|---|---|
| @FlashAlert_me | 10 |
| @InsiderAlerts4U | 8 |
| @SweepCastApp | 7 |
| @Tickeron | 5 |
| @MarcJacksonLA | 2 |
Recent Tweets for ALNY
 |
@newton93420295 Entries & exits Daily! Discord link below? https://t.co/nanIHuZbAL $ALNY May 28th 2022, 7:05pm |
 |
@ShortAlgoTrades $ALNY Trading Ideas | Awaiting Buy signal. 80% Profitability based on 8 trades. Profit factor is 141.28. Learn more… https://t.co/iKKcvTAenc May 27th 2022, 7:05pm |
 |
@Steve_382 @mRNAdisrupts The market evidently expects $ALNY to have a better revenue growth rate than $IONS. Whether that turn… https://t.co/VSfI5KISgI May 27th 2022, 2:05pm |
 |
@mRNAdisrupts $alny still trades around 19xs revenue more than 3xs that of $ions. #biotechnology #biotech @MorningstarInc… https://t.co/1HozxE18cD May 27th 2022, 2:05pm |
 |
@atimeywimey $ALNY 85.71% Profitability across 7 trades in 1 month. Profit Factor of 3.23 and rating is Bearish. Get started for… https://t.co/WDxlvcS5aM May 27th 2022, 1:05pm |
 |
@AlertTrade Trading Ideas: $ALNY with a Bullish outlook following its earnings #Stocks https://t.co/yicppdVOH8 ? FREE trade-of-… https://t.co/o81NOqATQS May 26th 2022, 5:05pm |
 |
@EpsMomentum $ALNY with a Bullish outlook following its earnings #Stocks - #ALNY chart on @TradingView https://t.co/WojECyb808 May 26th 2022, 5:05pm |
 |
@SweepCastApp SweepCast ? Unusual Options Observed : $ALNY with our scanner on $185 PUT Expiring: 01/20/2023 worth 27K? Start Yo… https://t.co/hyJDInuNR6 May 26th 2022, 3:05pm |
 |
@TradeWithAlerts Nice print for $ALNY Size: 126400 Price: 126.53 Amount: $15,993,392.00 Time: 1340 See more: https://t.co/sh8zd08y8i… https://t.co/xaRqoHJVwj May 25th 2022, 5:05pm |
|
@SweepCastApp SweepCast ? Unusual Options Observed : $ALNY with our scanner on $105 PUT Expiring: 08/19/2022 worth 65K? Start Yo… https://t.co/zpVM5P1MuA May 25th 2022, 2:05pm |
 |
@LeeSinTrade1 $ALNY 100% Win rate on 4 trades in 1 month. Rating is Bearish. Start Free Trial at https://t.co/z9Zossz5Nf https://t.co/0vJDf4Vi2w May 25th 2022, 2:05pm |
 |
@ShortAlgoKing $ALNY 100% Win rate on 4 trades in 1 month. Rating is Bearish. ? Stock Trading Ideas by https://t.co/qchl9O5K2n https://t.co/L2vQw1Cdes May 25th 2022, 11:05am |
|
@ShortAlgoTrades $ALNY 100% Profitability across 4 trades in 1 month. Rating is Bearish. Learn more at https://t.co/sjROqPnc9P… https://t.co/0L5J8uI2JN May 25th 2022, 7:05am |
 |
@Tickeron $ALNY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/24gJswfJsg May 24th 2022, 9:05pm |
 |
@MarcJacksonLA $ALNY Alnylam's Lumasiran Shows Clinical Benefit In Rare Kidney Disease $ALNY https://t.co/ccVORsugVw via @Benzinga May 24th 2022, 5:05pm |
 |
@newsfilterio Alnylam's Lumasiran Shows Clinical Benefit In Rare Kidney Disease $ALNY https://t.co/LpVR0tkbAd May 24th 2022, 5:05pm |
|
@Tickeron If you’re trading this week, Read This! $ALNY entered Uptrend as Momentum indicator ascends above 0 level.… https://t.co/L95HzFFrPH May 24th 2022, 2:05pm |
 |
@Briefingcom $ALNY: Alnylam Pharma presents new results from the ILLUMINATE-C phase 3 study of lumasiran in patients with... https://t.co/pqxIR92LfN May 24th 2022, 1:05pm |
 |
@MarketCurrents $ALNY - Alnylam kidney disorder therapy Oxlumo improves cardiac measures in new data from phase 3 trial https://t.co/EsmwXiEvFI May 24th 2022, 12:05pm |
 |
@invescent $ALNY Data indicates that the overall analyst sentiment for ALNY is bullish. Simplify the way you research stock… https://t.co/mFqwrZE3OZ May 24th 2022, 11:05am |
 |
@FlashAlert_me $ALNY [15s. delayed]: Issued Press Release on May 24, 07:00:00: Alnylam Presents New Results from the ILLUMINATE-C… https://t.co/hjaofwiOMh May 24th 2022, 11:05am |
 |
@StockNewsBot2 $ALNY Alnylam Presents New Results from the ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Prima… https://t.co/G9lZ3tDIrq May 24th 2022, 11:05am |
 |
@FastestAlert $ALNY Alnylam Presents New Results From The ILLUMINATE-C Phase 3 Study Of Lumasiran In Patients With Advanced Prima… https://t.co/kRGKVex9mt May 24th 2022, 11:05am |
 |
@stock_titan $ALNY Alnylam Presents New Results from the ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Prima… https://t.co/Q5RxnRaslI May 24th 2022, 11:05am |
 |
@WebChronicleTo1 $ALNY Alnylam Presents New Results from the ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Prima… https://t.co/r2nrSdXwtG May 24th 2022, 11:05am |
 |
@ShadowOptions Outside day tickers - $PENN $ALNY May 24th 2022, 3:05am |
|
@TradeWithAlerts Nice print for $ALNY Size: 259977 Price: 129.58 Amount: $33,687,819.66 Time: 1803 See more: https://t.co/sh8zd080iK… https://t.co/ZIzhhZdgMP May 23rd 2022, 10:05pm |
 |
@investor_feed $ALNY 8-K Alnylam Pharmaceuticals (23 May, 4:31pm) ? Submission of Matters to a Vote of Security Holders; Fina… https://t.co/4fyKFBj6Hg May 23rd 2022, 8:05pm |
 |
@OwenMar54200817 $ALNY Top Analyst price target today https://t.co/2izrP1g81o May 23rd 2022, 6:05pm |
|
@MarcJacksonLA $ALNY Alnylam Reports More Positive Data as Vutrisiran Awaits July FDA Date | BioSpace https://t.co/6gL7xT50DP #jobs May 23rd 2022, 1:05pm |
 |
@Prof_Oak_ Hard to extrapolate NT-proBNP from $ALNY HEALIOS-A subgroup, as BLs do not reflect CM-predominant pop (~800ng/L vs.… https://t.co/kEqh5yijRt May 23rd 2022, 1:05pm |
|
@FlashAlert_me $ALNY [15s. delayed]: Issued Press Release on May 23, 07:00:00: Alnylam Presents New 18-Month Results from Explorat… https://t.co/ZJ9MHevsFc May 23rd 2022, 11:05am |
|
@StockNewsBot2 $ALNY Alnylam Presents New 18-Month Results from Exploratory Cardiac Endpoints in HELIOS-A Phase 3 Study of Investi… https://t.co/tBVpPGemWi May 23rd 2022, 11:05am |
|
@FastestAlert $ALNY Alnylam Presents New 18-Month Results From Exploratory Cardiac Endpoints In HELIOS-A Phase 3 Study Of Investi… https://t.co/da9wVdcUxJ May 23rd 2022, 11:05am |
|
@stock_titan $ALNY Alnylam Presents New 18-Month Results from Exploratory Cardiac Endpoints in HELIOS-A Phase 3 Study of Investi… https://t.co/Uh6QQPJdsX May 23rd 2022, 11:05am |
|
@WebChronicleTo1 $ALNY Alnylam Presents New 18-Month Results from Exploratory Cardiac Endpoints in HELIOS-A Phase 3 Study of Investi… https://t.co/EO5k0THOhi May 23rd 2022, 11:05am |
 |
@MarketChmln $ALNY upcoming event May 24: H.C. Wainwright Global Investment Conference. Options expiring on June 17 that cover t… https://t.co/stayyNwtlk May 22nd 2022, 12:05pm |
|
@Tickeron $ALNY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/ILVhUUOrqe May 22nd 2022, 9:05am |
 |
@InsiderAlerts4U $ALNY: New Insider Filing on ALNYLAM PHARMACEUTICALS, INC.'s Director OLIVIER BRANDICOURT: https://t.co/JjFrIm8uQu May 21st 2022, 10:05am |
|
@InsiderAlerts4U $ALNY: New Insider Filing on ALNYLAM PHARMACEUTICALS, INC.'s Director PHILLIP A SHARP: https://t.co/USNsJk8pbV May 21st 2022, 7:05am |
|
@InsiderAlerts4U $ALNY: New Insider Filing on ALNYLAM PHARMACEUTICALS, INC.'s Director DENNIS A AUSIELLO: https://t.co/sfrChNLacr May 21st 2022, 6:05am |
|
@Tickeron How does this make you feel? $ALNY MACD Histogram turned positive on May 19, 2022. #AlnylamPharmaceuticals… https://t.co/ki7CNorobR May 21st 2022, 5:05am |
|
@InsiderAlerts4U $ALNY: New Insider Filing on ALNYLAM PHARMACEUTICALS, INC.'s Director AMY W SCHULMAN: https://t.co/pLT50uhnNR May 21st 2022, 3:05am |
|
@InsiderAlerts4U $ALNY: New Insider Filing on ALNYLAM PHARMACEUTICALS, INC.'s Director DAVID E I PYOTT: https://t.co/2TaduL0e8t May 20th 2022, 10:05pm |
|
@InsiderAlerts4U $ALNY: New Insider Filing on ALNYLAM PHARMACEUTICALS, INC.'s Director MARGARET A HAMBURG: https://t.co/Uup0Rezgm7 May 20th 2022, 9:05pm |
|
@InsiderAlerts4U $ALNY: New Insider Filing on ALNYLAM PHARMACEUTICALS, INC.'s Director MARSHA FANUCCI: https://t.co/RYoY3Y6RdV May 20th 2022, 9:05pm |
|
@InsiderAlerts4U $ALNY: New Insider Filing on ALNYLAM PHARMACEUTICALS, INC.'s Director COLLEEN F REITAN: https://t.co/2i6DQMzUdk May 20th 2022, 8:05pm |
|
@FlashAlert_me $ALNY [15s. delayed] filed SEC form 4: Director PYOTT DAVID E I: Transacted Derivative Securities on 2022-05-18. https://t.co/gHmENSV0xX May 20th 2022, 8:05pm |
|
@FlashAlert_me $ALNY [15s. delayed] filed SEC form 4: Director HAMBURG MARGARET A: Transacted Derivative Securities on 2022-05-18… https://t.co/VtgVSSOHZH May 20th 2022, 8:05pm |
|
@FlashAlert_me $ALNY [15s. delayed] filed SEC form 4: Director Reitan Colleen F: Transacted Derivative Securities on 2022-05-18. https://t.co/5rEALa1I9J May 20th 2022, 8:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.